Predictive performance and metabolite dynamics of proton MR spectroscopy in neonatal hypoxic-ischemic encephalopathy.
Journal
Pediatric research
ISSN: 1530-0447
Titre abrégé: Pediatr Res
Pays: United States
ID NLM: 0100714
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
received:
12
01
2021
accepted:
07
06
2021
revised:
26
04
2021
pubmed:
8
9
2021
medline:
12
4
2022
entrez:
7
9
2021
Statut:
ppublish
Résumé
Prognostic value of proton MR spectroscopy (H-MRS) in hypoxic-ischemic encephalopathy (HIE) is acknowledged; however, effects of gestational age (GA) and postnatal age (PA) on prediction and metabolite levels are unknown. One hundred and sixty-nine newborns with moderate-to-severe HIE were studied, having ≥1 H-MRS scan during postnatal days 0-14 and known neurodevelopmental outcome (Bayley-II score/cerebral palsy/death). Initial scans were categorized by PA (day 1-3/4-6/≥7), and metabolite ratios were compared by predictive value. Metabolite dynamics were assessed in a total of 214 scans performed in the study population, using regression modeling, with predictors GA, PA, and outcome. N-acetyl-aspartate (NAA)/creatine (Cr) and myo-inositol (mI)/NAA height ratios were consistently associated with outcome throughout the first 14 days, with the highest predictive value in the late (≥7 days) period (AUC = 0.963 and 0.816, respectively). Neither GA nor PA had an overall effect on these metabolite ratios, which showed strongest association with outcome (p < 0.001). Assessed separately in patients with good outcome, GA became a significant covariate for metabolite ratios (p = 0.0058 and 0.0002, respectively). However, this association disappeared in the poor outcome group. In HIE, NAA/Cr and mI/NAA give most accurate outcome prediction throughout postnatal days 0-14. GA only affected metabolite levels in the good outcome group. Proton MR spectroscopy metabolite ratios N-acetyl-aspartate/creatine and myo-inositol/N-acetyl-aspartate have persistently high predictive value throughout postnatal days 0-14 in newborns with hypoxic-ischemic encephalopathy, with the highest predictive power between postnatal days 7 and 14. Overall, neither metabolite ratio was affected by gestational age nor by postnatal age, while they showed the strongest association with neurological outcome. However, in newborns facing good outcome, metabolite ratios were associated with gestational age, whereas in cases facing poor outcome, this association disappeared. Proton MR spectroscopy provides valuable prognostic information in neonatal hypoxic-ischemic encephalopathy throughout the first 2 weeks of life, irrespective of the timing of MR scan.
Sections du résumé
BACKGROUND
Prognostic value of proton MR spectroscopy (H-MRS) in hypoxic-ischemic encephalopathy (HIE) is acknowledged; however, effects of gestational age (GA) and postnatal age (PA) on prediction and metabolite levels are unknown.
METHODS
One hundred and sixty-nine newborns with moderate-to-severe HIE were studied, having ≥1 H-MRS scan during postnatal days 0-14 and known neurodevelopmental outcome (Bayley-II score/cerebral palsy/death). Initial scans were categorized by PA (day 1-3/4-6/≥7), and metabolite ratios were compared by predictive value. Metabolite dynamics were assessed in a total of 214 scans performed in the study population, using regression modeling, with predictors GA, PA, and outcome.
RESULTS
N-acetyl-aspartate (NAA)/creatine (Cr) and myo-inositol (mI)/NAA height ratios were consistently associated with outcome throughout the first 14 days, with the highest predictive value in the late (≥7 days) period (AUC = 0.963 and 0.816, respectively). Neither GA nor PA had an overall effect on these metabolite ratios, which showed strongest association with outcome (p < 0.001). Assessed separately in patients with good outcome, GA became a significant covariate for metabolite ratios (p = 0.0058 and 0.0002, respectively). However, this association disappeared in the poor outcome group.
CONCLUSIONS
In HIE, NAA/Cr and mI/NAA give most accurate outcome prediction throughout postnatal days 0-14. GA only affected metabolite levels in the good outcome group.
IMPACT
Proton MR spectroscopy metabolite ratios N-acetyl-aspartate/creatine and myo-inositol/N-acetyl-aspartate have persistently high predictive value throughout postnatal days 0-14 in newborns with hypoxic-ischemic encephalopathy, with the highest predictive power between postnatal days 7 and 14. Overall, neither metabolite ratio was affected by gestational age nor by postnatal age, while they showed the strongest association with neurological outcome. However, in newborns facing good outcome, metabolite ratios were associated with gestational age, whereas in cases facing poor outcome, this association disappeared. Proton MR spectroscopy provides valuable prognostic information in neonatal hypoxic-ischemic encephalopathy throughout the first 2 weeks of life, irrespective of the timing of MR scan.
Identifiants
pubmed: 34489532
doi: 10.1038/s41390-021-01626-z
pii: 10.1038/s41390-021-01626-z
pmc: PMC8904256
doi:
Substances chimiques
Protons
0
Aspartic Acid
30KYC7MIAI
Inositol
4L6452S749
Creatine
MU72812GK0
Choline
N91BDP6H0X
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
581-589Informations de copyright
© 2021. The Author(s).
Références
Mcintyre, S., Badawi, N., Blair, E. & Nelson, K. B. Does aetiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy influence the outcome of treatment? Dev. Med. Child Neurol. 57, 2–7 (2015).
doi: 10.1111/dmcn.12725
Hassell, K. J., Ezzati, M., Alonso-Alconada, D., Hausenloy, D. J. & Robertson, N. J. New horizons for newborn brain protection: enhancing endogenous neuroprotection. Arch. Dis. Child. Fetal Neonatal Ed. 100, F541–F552 (2015).
doi: 10.1136/archdischild-2014-306284
Hankins, G. D. V. & Speer, M. Defining the pathogenesis and pathophysiology of neonatal encephalopathy and cerebral palsy. Obstet. Gynecol. 102, 628–636 (2003).
pubmed: 12962954
Lally, P. J. et al. Magnetic resonance spectroscopy assessment of brain injury after moderate hypothermia in neonatal encephalopathy: a prospective multicentre cohort study. Lancet Neurol. 18, 35–45 (2019).
doi: 10.1016/S1474-4422(18)30325-9
Thayyil, S. et al. Cerebral magnetic resonance biomarkers in neonatal encephalopathy: a meta-analysis. Pediatrics 125, e382–e395 (2010).
doi: 10.1542/peds.2009-1046
Shibasaki, J. et al. Changes in brain metabolite concentrations after neonatal hypoxic-ischemic encephalopathy. Radiology 288, 840–848 (2018).
doi: 10.1148/radiol.2018172083
Urbanik, A., Cichocka, M., Kozub, J., Karcz, P. & Herman-Sucharska, I. Evaluation of changes in biochemical composition of fetal brain between 18th and 40th gestational week in proton magnetic resonance spectroscopy. J. Matern. Fetal Neonatal Med. 32, 2493–2499 (2019).
doi: 10.1080/14767058.2018.1439009
Azzopardi, D. et al. The TOBY Study. Whole body hypothermia for the treatment of perinatal asphyxial encephalopathy: a randomised controlled trial. BMC Pediatr. 8, 17 (2008).
doi: 10.1186/1471-2431-8-17
Barta, H. et al. Prognostic value of early, conventional proton magnetic resonance spectroscopy in cooled asphyxiated infants. BMC Pediatr. 18, 302 (2018).
doi: 10.1186/s12887-018-1269-6
Shalak, L. F., Laptook, A. R., Velaphi, S. C. & Perlman, J. M. Amplitude-integrated electroencephalography coupled with an early neurologic examination enhances prediction of term infants at risk for persistent encephalopathy. Pediatrics 111, 351–357 (2003).
doi: 10.1542/peds.111.2.351
Bottomley, P. A. The trouble with spectroscopy papers. Radiology 181, 344–350 (1991).
doi: 10.1148/radiology.181.2.1924769
The American Academy of Pediatrics. The American College of Obstetricians and Gynecologists. Executive summary: Neonatal Encephalopathy and Neurologic Outcome, Second Edition. Obstet. Gynecol. 123, 896–901 (2014).
doi: 10.1097/01.AOG.0000445580.65983.d2
Kok, R. D., van den Berg, P. P., van den Bergh, A. J., Nijland, R. & Heerschap, A. Maturation of the human fetal brain as observed by 1H MR spectroscopy. Magn. Reson. Med. 48, 611–616 (2002).
doi: 10.1002/mrm.10264
Cheong, J. L. Y. et al. Proton MR spectroscopy in neonates with perinatal cerebral hypoxic-ischemic injury: metabolite peak-area ratios, relaxation times, and absolute concentrations. AJNR Am. J. Neuroradiol. 27, 1546–1554 (2006).
pubmed: 16908578
pmcid: 7977542
Alderliesten, T. et al. MRI and spectroscopy in (near) term neonates with perinatal asphyxia and therapeutic hypothermia. Arch. Dis. Child. Fetal Neonatal Ed. 102, F147–F152 (2017).
doi: 10.1136/archdischild-2016-310514
van Doormaal, P. J., Meiners, L. C., ter Horst, H. J., van der Veere, C. N. & Sijens, P. E. The prognostic value of multivoxel magnetic resonance spectroscopy determined metabolite levels in white and grey matter brain tissue for adverse outcome in term newborns following perinatal asphyxia. Eur. Radiol. 22, 772–778 (2012).
doi: 10.1007/s00330-011-2315-z
Lange, T. et al. Pitfalls in lactate measurements at 3T. AJNR Am. J. Neuroradiol. 27, 895–901 (2006).
pubmed: 16611787
pmcid: 8133981
Whu, T. W. et al. Cerebral lactate concentration in neonatal hypoxic-ischemic encephalopathy: in relation to time, characteristic of injury, and serum lactate concentration. Front. Neurol. 11, 293 (2018).
Sijens, P. E., Wischniowsky, K. & ter Horst, H. J. The prognostic value of proton magnetic resonance spectroscopy in term newborns treated with therapeutic hypothermia following asphyxia. Magn. Reson. Imaging 42, 82–87 (2017).
doi: 10.1016/j.mri.2017.06.001
Erecinska, M., Thoresen, M. & Silver, I. A. Effects of hypothermia on energy metabolism in mammalian central nervous system. J. Cereb. Blood Flow Metab. 23, 513–530 (2003).
doi: 10.1097/01.WCB.0000066287.21705.21
Robertson, N. J. et al. Early increases in brain myo-inositol measured by proton magnetic resonance spectroscopy in term infants with neonatal encephalopathy. Pediatr. Res. 50, 692–700 (2001).
doi: 10.1203/00006450-200112000-00011
Macrì, M. A. et al. Regional changes in the metabolite profile after long-term hypoxia-ischemia in brains of young and aged rats: a quantitative proton MRS study. Neurobiol. Aging 27, 98–104 (2006).
doi: 10.1016/j.neurobiolaging.2005.01.007
Brighina, E., Bresolin, N., Pardi, G. & Rango, M. Human fetal brain chemistry as detected by proton magnetic resonance spectroscopy. Pediatr. Neurol. 40, 327–342 (2009).
doi: 10.1016/j.pediatrneurol.2008.11.001